Experts at PMWC 2026 emphasized that regulatory‑grade real‑world data in oncology will require prospectively collected, harmonized datasets that integrate multimodal clinical information.
- Trends In FDA FY 2025 Warning Letters
- SUS Interchangeability Assessment And Qualification Best Practices
- Delivery Strategy For Next-Gen Cardiac Gene Therapies
- Accelerating Technology Diffusion In Cell And Gene Therapy
- The In Vivo Cell Therapy Shift On Display At PMWC 2026
- Inside SynaptixBio's Mission To Develop A Therapy For H-ABC
- 5 QMS Blind Spots You Should Know About
- New MIT Consortium Links Innovation With Real-World Biomanufacturing
CELL & GENE ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
Enhanced T Cell Expansion While Maintaining Early Memory Cell Phenotype
Study the development and performance of this animal origin-free (AOF) T cell culture medium designed for T cell expansion through an experiment comparing it to other AOF or xeno-free basal offerings.
-
A Bright Future For Eye Care: The Advanced Therapy Revolution Is Here
Groundbreaking cell and gene therapies are revolutionizing eye care. Discover how advanced treatments target root causes, offering unprecedented hope for conditions previously deemed untreatable.
-
Redefining Accessibility For Pediatric Patients
Explore how meeting patients where they are can redefine what successful pediatric trial delivery looks like.
-
Seed Train Intensification Using High Cell Density Cryopreservation
Streamline your upstream bioprocessing with seed train intensification. Discover how high cell density cryopreservation reduces scale-up time, boosts consistency, and enhances manufacturing flexibility.
-
ISO 21973: How To Ensure Full Compliance Throughout Every Step Of The Journey
Learn how ISO 21973, a vital standard for ensuring safe and reliable transport of cell and gene therapies, enhances supply chain efficiency and mitigates risks for the regenerative medicine industry.
-
Extractables In Single-Use Systems Used In ADC Manufacturing
To address concerns about using organic solvents in the ADC process, extractables studies were conducted on a disposable chromatography column housing and two different disposable flow paths.
-
Comparing Process Development Approaches For Recombinant Proteins
Explore how adding a traceless tag enables streamlined affinity purification for recombinant proteins, and how this approach compares with a conventional process in development time, recovery, and purity.
-
Quantifying Lentiviral Physical Titer
Streamline lentiviral vector analytics with our direct RT-dPCR method. Achieve precise, reproducible results to accelerate safe, effective gene therapies with enhanced quality control.
-
A Paradigm Shift From Glass Benchtop Bioreactors
Learn how a bench-scale single-use bioreactor offers process development advantages over traditional glass systems, including higher efficiency, increased productivity, and enhanced sustainability.
-
Demonstration Of Scalability For A Novel Fixed Bed Reactor Platform
Designed to enable efficient scalability, a new FBR platform allows operators to use one technology, with a standardized workflow, for their process development, scale-up, and manufacturing processes.
NEWSLETTER ARCHIVE
- 03.14.26 -- Cell & Gene Best Of February
- 03.13.26 -- Green Supply Chains Rarely Start With A Pledge; Target Waste Instead
- 03.12.26 -- Six Specialized Modalities Testing CDMO Readiness In 2026
- 03.11.26 -- Are You Scaling CGT Wrong?
- 03.11.26 -- Regulators Maintain Consistent Endpoints While Raising Evidence Standards
CELL AND GENE CONTENT COLLECTIONS
While there are opportunities to scale, there are also manufacturing gaps, capacity issues, and production timelines that require improvement to do so. And then, of course, there’s cost. Because scale up and scale out are significant to everyone in the sector, we’ve curated insightful editorial that addresses the most important aspects of scalability.
More Content Collections